25 results on '"Abrams, Jeffrey S"'
Search Results
2. Nivolumab Is Effective in Mismatch Repair–Deficient Noncolorectal Cancers: Results From Arm Z1D—A Subprotocol of the NCI-MATCH (EAY131) Study
3. Preliminary Data Release for Randomized Clinical Trials of Noninferiority: A New Proposal
4. Bias, Operational Bias, and Generalizability in Phase II/III Trials
5. Meeting the Challenge: The National Cancer Institute’s Central Institutional Review Board for Multi-Site Research
6. Leading the way: The National Cancer Institute’s (NCI) single IRB for multi-site research.
7. Analysis of potential disparities by race, ethnicity, and age in adult accruals to NCI National Clinical Trials Network (NCTN) breast, lung, prostate, and colorectal trials.
8. Transparency around disapproval reasons of early-phase trial proposals submitted to the National Cancer Institute (NCI).
9. Evaluating year 1 of NCI's experimental therapeutics clinical trials network (ETCTN).
10. Readability and compliance of NCI's informed consent documents (ICDs) with its revised ICD template.
11. Creating a national collaborative strategy to enhance trial accrual in NCI’s National Clinical Trials Network (NCTN) in the era of precision medicine.
12. ALCHEMIST: a clinical trial platform to bring genomic discovery and molecularly targeted therapies to early-stage lung cancer.
13. Improving the Protocol Implementation Process: The National Cancer Institute's Response
14. A randomized, controlled study comparing NCI’s original and revised informed consent templates.
15. NCI pilot intervention program to assist accrual for challenging late-phase clinical trials.
16. Design Issues in Randomized Phase II/III Trials
17. Reply to M. Buyse et al
18. Overall Survival As the Outcome for Randomized Clinical Trials With Effective Subsequent Therapies
19. Accrual Experience of National Cancer Institute Cooperative Group Phase III Trials Activated From 2000 to 2007
20. Optimizing Collection of Adverse Event Data in Cancer Clinical Trials Supporting Supplemental Indications
21. Improving Cancer Outcomes Through International Collaboration in Academic Cancer Treatment Trials
22. Late Extended Adjuvant Treatment With Letrozole Improves Outcome in Women With Early-Stage Breast Cancer Who Complete 5 Years of Tamoxifen
23. Patient-Reported Outcomes Assessment in Cancer Trials: Taking Stock, Moving Forward
24. Efficacy of Letrozole Extended Adjuvant Therapy According to Estrogen Receptor and Progesterone Receptor Status of the Primary Tumor: National Cancer Institute of Canada Clinical Trials Group MA.17
25. Survival Is Not a Good Outcome for Randomized Trials With Effective Subsequent Therapies.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.